The Global Cardioselective Beta Blockers Market is a cornerstone of the pharmaceutical industry’s cardiovascular division, representing a refined class of medications specifically designed to treat heart-related conditions with greater precision than their non-selective predecessors. In 2025, these medications remain a frontline defense against the growing global burden of hypertension,...